Literature DB >> 22886529

No renal protection from volatile-anesthetic preconditioning in open heart surgery.

Wacharin Sindhvananda1, Krit Phisaiphun, Prut Prapongsena.   

Abstract

PURPOSE: Acute kidney injury (AKI) is a common complication of open heart surgery (OHS). Preconditioning with volatile anesthetics is well proven to provide myocardial protection. Renal protection provided by volatile-anesthetic preconditioning has also been investigated; however, it is still controversial at the clinical level. This study aimed to investigate whether preconditioning with volatile anesthetics could mediate renal protection in OHS.
METHODS: A retrospective analytic study was designed. Medical records of patients (age ≥20 years) who had undergone OHS were reviewed. Types of anesthesia were classified as 'opioid-based anesthesia' (O group) and 'volatile-anesthetic-based anesthesia' (V group) according to the definitions given in the main text. Some medical records that had incomplete or ambiguous data were excluded. Renal protection was considered to be present if there was no clinical renal dysfunction as defined by the criteria given in the main text. AKI was considered to be present when there was a decrease of the postoperative estimated glomerular filtration rate (eGFR) that was >25 % of the preoperative eGFR. Also, postoperative 24-h oliguria (post-oliguria) and the provision of postoperative 48-h dialysis (post-dialysis) were considered. Differences between the O and V groups were tested by the appropriate statistics. A p value of <0.05 indicated significance.
RESULTS: A total of 1,122 patients (702 males) were included in this study. The O and V groups included 704 and 418 patients, respectively. AKI was present in 9.52 and 8.37 % of the patients in the O and V groups, respectively (p = 0.532). Post-oliguria was found in 36.08 and 37.79 % of the patients in the O and V groups; and post-dialysis was provided in 3.98 and 4.31 %, respectively, of these patients; these two parameters showed no significant differences between the groups.
CONCLUSIONS: This study could not demonstrate volatile-anesthetic-mediated renal protection in OHS. Therefore, in practice, pharmacological preconditioning with volatile anesthetics did not seem to be beneficial.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886529     DOI: 10.1007/s00540-012-1461-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  36 in total

1.  Perioperative acute kidney injury: risk factors, recognition, management, and outcomes.

Authors:  Emma Borthwick; Andrew Ferguson
Journal:  BMJ       Date:  2010-07-05

2.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

Review 3.  Ischaemic preconditioning: from molecular characterisation to clinical application--part II.

Authors:  N P Riksen; P Smits; G A Rongen
Journal:  Neth J Med       Date:  2004-12       Impact factor: 1.422

Review 4.  Ischemic preconditioning of myocardium.

Authors:  Priya Tyagi; Girish Tayal
Journal:  Acta Pharmacol Sin       Date:  2002-10       Impact factor: 6.150

Review 5.  Volatile anesthetics and cardiac function.

Authors:  Stefan G De Hert
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2006-03

6.  Ischaemic preconditioning protects the rat kidney from reperfusion injury.

Authors:  N Toosy; E L McMorris; P A Grace; R T Mathie
Journal:  BJU Int       Date:  1999-09       Impact factor: 5.588

Review 7.  Mitogen-activated protein kinases in hemostasis and thrombosis.

Authors:  F Adam; A Kauskot; J-P Rosa; M Bryckaert
Journal:  J Thromb Haemost       Date:  2008-12       Impact factor: 5.824

8.  Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.

Authors:  Minjae Kim; Mihwa Kim; Nala Kim; Vivette D D'Agati; Charles W Emala; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2007-09-26

9.  Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.

Authors:  Karine Julier; Rafaela da Silva; Carlos Garcia; Lukas Bestmann; Philippe Frascarolo; Andreas Zollinger; Pierre-Guy Chassot; Edith R Schmid; Marko I Turina; Ludwig K von Segesser; Thomas Pasch; Donat R Spahn; Michael Zaugg
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

10.  Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery.

Authors:  Jay L Koyner; Michael R Bennett; Elaine M Worcester; Qing Ma; Jai Raman; Valluvan Jeevanandam; Kristen E Kasza; Michael F O'Connor; David J Konczal; Sharon Trevino; Prasad Devarajan; Patrick T Murray
Journal:  Kidney Int       Date:  2008-07-23       Impact factor: 10.612

View more
  2 in total

Review 1.  Cellular signaling pathways and molecular mechanisms involving inhalational anesthetics-induced organoprotection.

Authors:  Lingzhi Wu; Hailin Zhao; Tianlong Wang; Chen Pac-Soo; Daqing Ma
Journal:  J Anesth       Date:  2014-03-09       Impact factor: 2.078

2.  Isoflurane reduces pain and inhibits apoptosis of myocardial cells through the phosphoinositide 3-kinase/protein kinase B signaling pathway in mice during cardiac surgery.

Authors:  Zhibing Pi; Hai Lin; Jianping Yang
Journal:  Mol Med Rep       Date:  2018-02-27       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.